Core Scientific's Largest Shareholder, Two Seas Capital, Urges Vote Against Proposed Sale to CoreWeave, Citing Flawed Deal and Undervaluation

Reuters

Oct 13

<a href="https://laohu8.com/S/CORZ">Core Scientific</a>'s Largest Shareholder, Two Seas Capital, Urges Vote Against Proposed Sale to CoreWeave, Citing Flawed Deal and Undervaluation

Core Scientific Inc. is the subject of a proposed sale to CoreWeave, Inc., as announced on July 7, 2025. The transaction has drawn attention from major shareholders, with Two Seas Capital LP, the largest active shareholder of Core Scientific, publicly opposing the deal. Two Seas Capital released an investor presentation highlighting concerns about the transaction process, deal structure, and valuation, noting that Core Scientific's stock performance has lagged behind its peers since the announcement. The presentation argues that the proposed terms undervalue Core Scientific and ties its future to what is described as CoreWeave's underperforming stock.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Scientific Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE95908) on October 13, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2575018274"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2575018274\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2575018274?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-13 21:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575018274","market":"us","top_or_hot":-1,"title":"Core Scientific's Largest Shareholder, Two Seas Capital, Urges Vote Against Proposed Sale to CoreWeave, Citing Flawed Deal and Undervaluation","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/CORZ\">Core Scientific</a>'s Largest Shareholder, Two Seas Capital, Urges Vote Against Proposed Sale to CoreWeave, Citing Flawed Deal and Undervaluation\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/CORZQ\">Core Scientific</a> Inc. is the subject of a proposed sale to <a href=\"https://laohu8.com/S/CRWV\">CoreWeave, Inc.</a>, as announced on July 7, 2025. The transaction has drawn attention from major shareholders, with Two Seas Capital LP, the largest active shareholder of <a href=\"https://laohu8.com/S/CRZWQ\">Core Scientific</a>, publicly opposing the deal. Two Seas Capital released an investor presentation highlighting concerns about the transaction process, deal structure, and valuation, noting that Core Scientific's stock performance has lagged behind its peers since the announcement. The presentation argues that the proposed terms undervalue Core Scientific and ties its future to what is described as CoreWeave's underperforming stock.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Scientific Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE95908) on October 13, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Core Scientific's Largest Shareholder, Two Seas Capital, Urges Vote Against Proposed Sale to CoreWeave, Citing Flawed Deal and Undervaluation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCore Scientific's Largest Shareholder, Two Seas Capital, Urges Vote Against Proposed Sale to CoreWeave, Citing Flawed Deal and Undervaluation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-13 21:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/CORZ\">Core Scientific</a>'s Largest Shareholder, Two Seas Capital, Urges Vote Against Proposed Sale to CoreWeave, Citing Flawed Deal and Undervaluation\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/CORZQ\">Core Scientific</a> Inc. is the subject of a proposed sale to <a href=\"https://laohu8.com/S/CRWV\">CoreWeave, Inc.</a>, as announced on July 7, 2025. The transaction has drawn attention from major shareholders, with Two Seas Capital LP, the largest active shareholder of <a href=\"https://laohu8.com/S/CRZWQ\">Core Scientific</a>, publicly opposing the deal. Two Seas Capital released an investor presentation highlighting concerns about the transaction process, deal structure, and valuation, noting that Core Scientific's stock performance has lagged behind its peers since the announcement. The presentation argues that the proposed terms undervalue Core Scientific and ties its future to what is described as CoreWeave's underperforming stock.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Scientific Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE95908) on October 13, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4023","symbol_name":"应用软件","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nNDLbg0BT2:1","article_id":"2575018274","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2575018274","pubTimestamp":1760360543,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Core Scientific's Largest Shareholder, Two Seas Capital, Urges Vote Against Proposed Sale to CoreWeave, Citing Flawed Deal and Undervaluation. Core Scientific Inc. is the subject of a proposed sale to CoreWeave, Inc., as announced on July 7, 2025. The transaction has drawn attention from major shareholders, with Two Seas Capital LP, the largest active shareholder of Core Scientific, publicly opposing the deal. Two Seas Capital released an investor presentation highlighting concerns about the transaction process, deal structure, and valuation, noting that Core Scientific's stock performance has lagged behind its peers since the announcement. The presentation argues that the proposed terms undervalue Core Scientific and ties its future to what is described as CoreWeave's underperforming stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4023":"应用软件","CORZ":"Core Scientific, Inc.","CRWV":"CoreWeave, Inc.","BK4608":"AI应用概念股","BK4116":"互联网服务与基础架构"},"translate_title":"Core Scientific最大股东Two Seas Capital敦促投票反对向CoreWeave出售的提议，理由是交易存在缺陷且估值被低估","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CORZ":0.9,"CRWV":0.9},"content_text":"Core Scientific's Largest Shareholder, Two Seas Capital, Urges Vote Against Proposed Sale to CoreWeave, Citing Flawed Deal and Undervaluation\n    \n\nCore Scientific Inc. is the subject of a proposed sale to CoreWeave, Inc., as announced on July 7, 2025. The transaction has drawn attention from major shareholders, with Two Seas Capital LP, the largest active shareholder of Core Scientific, publicly opposing the deal. Two Seas Capital released an investor presentation highlighting concerns about the transaction process, deal structure, and valuation, noting that Core Scientific's stock performance has lagged behind its peers since the announcement. The presentation argues that the proposed terms undervalue Core Scientific and ties its future to what is described as CoreWeave's underperforming stock.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Scientific Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE95908) on October 13, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}